Ken Fisher Gilead Sciences, Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 10,606 shares of GILD stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,606
Previous 8,950
18.5%
Holding current value
$1.19 Million
Previous $750,000
30.53%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding GILD
# of Institutions
2,094Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.03 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.76 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.49 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...